Biotechnology Innovation Organization v. Azar

U.S. District Court for the Northern District of California

Tab Group

Merits Stage

Preliminary injunction granted against MFN Drug Pricing Rule

December 28, 2020

Click here to view the opinion. The judge’s opinion reflects our arguments--and, in particular, our victory in the U.S. Chamber v. DHS case, which the Court cited in its opinion.

U.S. Chamber files coalition amicus brief urging Northern District of California to enjoin the “Most-Favored Nation Rule” given the administration’s failure to comply with the APA and abuse of the “good-cause” exception

December 17, 2020

Click here to view the amicus brief filed by the U.S. Chamber and National Association of Manufacturers. Paul W. Hughes, Andrew A. Lyons-Berg, and William G. Gaede, III of McDermott Will & Emery LLP and the U.S. Chamber’s Litigation Center served as co-counsel for the U.S. Chamber.

Case Documents

U.S. Chamber & NAM Amicus Brief -- Biotechnology Innovation Organization v. Azar (N.D. Cal.).pdf

Order Granting Motion for Preliminary Injunction -- Biotechnology Innovation Organization v. Azar (N.D. Cal.).pdf